Impel Neuropharma Inc expected to post a loss of 75 cents a share - Earnings Preview

IPI Legacy Liquidation Co

12/11/2021 19:31

* Impel Neuropharma Inc  IMPL.OQ   IMPL.O  is expected to report
results on November 15.
​* Refinitiv's mean analyst estimate for Impel Neuropharma Inc
is for a loss of 75 cents per share. 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Impel
Neuropharma Inc is $50​, about 76.5% above​ its last closing
price of $11.77. ​​​
This summary was machine generated November 12 at 19:31 GMT. 
All figures in US dollars  unless otherwise stated